have analyzed the Mesp1 and/or Mesp2 enhancers and identified P1-PSME, a PSM-specific enhancer of Mesp1, which contains a T-box binding site similar to the previously identified P2-PSME. Hence, Mesp1 and Mesp2 use different enhancers for their PSM-specific expression. In addition, we find that these two genes also use distinct enhancers for their early mesodermal expression. Based on these results, we generated a PSM-specific Mesp1/ Mesp2-null mouse by introducing a BAC clone, from which only early mesodermal Mesp1 expression is possible, into the Mesp1/Mesp2 double knockout (dKO) genetic background.
Introduction
Somitogenesis is one of the most dynamic morphogenetic events that occur during early development in the mouse. Somites are formed one by one from the anterior end of the presomitic mesoderm (PSM), which is supplied from the primitive streak or tailbud at a later stage of development. The Mesp1 and Mesp2 genes encode bHLH transcription factors and are located close to each other on chromosome 7. Both of these genes are co-expressed in the nascent mesoderm cells ingressing from E6.25 to E7.5, and also in the anterior PSM from E8.0, in which they show a dynamic and periodic expression pattern.
In our previous study using a conventional transgenic strategy, we mapped the enhancer activities required for early mesoderm expression of Mesp1 (P1-EME, stands for Mesp1 early mesoderm enhancer) in a region approximately 4 kb upstream of the Mesp1 coding region, and for the presomitic mesodermal expression of Mesp2 (P2-PSME, stands for Mesp2 presomitic mesoderm enhancer), located within a 185 bp upstream region of the Mesp2 coding region (Haraguchi et al., 2001 ). In addition, we more recently identified that a T-box transcription factor, Tbx6, is essential for P2-PSME activity . However, it is not certain whether these enhancers act exclusively on the nearest gene or on both the Mesp1 and Mesp2, since these genes are in close prox- The functions of Mesp1 and Mesp2 have been further analyzed using knockout mice. A single replacement-type knockout of the Mesp1 gene with a pgk-neo cassette results in defective heart morphogenesis causing cardia bifida, whereas somitogenesis is not compromised (Saga et al., 1996 (Saga et al., , 1999 . In contrast, Mesp2-null mice show no defects in early mesoderm formation, but somitogenesis is severely affected in this knockout (Morimoto et al., 2005; Saga et al., 1997; Takahashi et al., 2000 Takahashi et al., , 2003 . These results indicate that Mesp1 functions in early mesoderm formation, whilst Mesp2 functions during somitogenesis. However, from our earlier study in which we replaced the Mesp2 genes with Mesp1 cDNA, we have already demonstrated that these two genes share similar functions, as each can rescue the knockout phenotype of the other (Saga, 1998) .
We have previously generated several Mesp2-null mice including Mesp2-null with pgk-neo (Mesp2 neo/neo ), Mesp2-LacZ knockin with pgk-neo (Mesp2
LacZ/LacZ
) and Mesp2-MCM knockin without pgk-neo, (Mesp2
MCM/MCM
), all of which showed defective somitogenesis but with different degrees of severity Saga et al., 1997; Takahashi et al., 2000 Takahashi et al., , 2007 . These differences seemed to be due to the presence or absence of the pgk-neo cassette, which attenuates the expression of the Mesp1 gene. The Mesp2
MCM/MCM mice may thus be truly Mesp2-null as the pgk-neo cassette was removed from the targeted allele. However, we found that the Mesp1 expression levels are up-regulated in these knockouts compared with the wild-type embryo. In contrast, in Mesp2 lacZ/lacZ and Mesp2 neo/neo mice, which contain a pgk-neo cassette, the expression of Mesp1 was attenuated. The phenotypic difference which is most prominent for these two groups is the disruption of the somite boundary formation, which is most likely to be rescued by Mesp1 in Mesp2 MCM/MCM mice because of the functional redundancy between Mesp1 and Mesp2 (Saga, 1998) . We had generated a double knockout (dKO) mouse for these two genes, but the resulting mice displayed early gastrulation defects, lacked most of their embryonic mesoderm, and did not generate a paraxial mesoderm which is required for somite formation . To more fully elucidate the functions of the Mesp proteins during somitogenesis, it was crucial to generate a PSM-specific Mesp1/Mesp2 double knockout (dKO) mouse. However, since these genes are located on the same chromosome and are both expressed in the early mesoderm, a conditional knockout would have been extremely difficult to produce. If both genes had shared a sole enhancer for PSM-specific expression, it may have been possible to generate an enhancer-KO mouse that would be null for both genes in the PSM. However, we had already determined that this was not the case.
As an alternative method, we devised a strategy to generate a PSM-specific dKO state for these genes by introducing a transgene which would express Mesp1 or Mesp2 in a dKO embryo but in the early mesoderm only. To achieve this, we employed a BAC transgenic strategy. We obtained a BAC clone in which the endogenous expression of both Mesp1 and Mesp2 is reproduced and in which we could also define the PSM enhancer for both genes. Using a BAC recombination method, we subsequently generated a transgene that lacks expression of both genes in the PSM but retains Mesp1 expression in the early mesoderm. We were thereby able to rescue the early gastrulation defects of the dKO mouse, and this enabled us to analyze somitogenesis in the absence of both Mesp1 and Mesp2. The resulting phenotype was quite similar to that of the Mesp2 lacZ/lacZ mouse, which displays the most severe Mesp2-null phenotype.
Results

BAC modification using sequential homologous recombination via different FRT sites
To generate a PSM-specific Mesp1 and Mesp2-null mouse, our approach was to achieve the early mesoderm-specific rescue of Mesp1 and Mesp2 double knockout (dKO) mouse by either of these genes. For this purpose, we required a BAC clone which would reproduce the endogenous expression of Mesp1 and Mesp2 in the early mesoderm. We successfully obtained such a clone (PR24-261C8) spanning 160 kb and containing a total of five genes, Plin, Pex11a, Anpep, Mesp1 and Mesp2 (Fig. 1A) . Because Plin, Pex11a and Anpep are not expressed during early development (data not shown), we anticipated that these genes would not affect the events occurring at this stage of embryogenesis despite their increased dosage. To determine whether this BAC clone contained all of the cisregulatory elements required for Mesp1 and Mesp2 expression, we introduced the reporter genes ALP into the Mesp1 and nLacZ into the Mesp2 locus via k recombinase mediated homologous recombination (Section 4, Fig. 1A and B). These reporter genes were recombined sequentially using different kanamycin vector cassettes containing different FRT sequences (FRT for nlacZ and FRT5 for ALP) (Fig. 1B and C) (Schlake and Bode, 1994) . This resulted in the establishment of a new BAC construct, designated BAC-P1AP-P2Z (stands for BAC-Mesp1ALP-Mesp2LacZ).
Subsequent transient transgenic analyses confirmed the co-expression of these reporters in both the anterior PSM and segmented somites because of the stable expression of ALP and b-gal proteins in these structures (Fig. 1D, a-d) . The activities of both reporters were also detectable in the early mesoderm lineage (Fig. 1D , e and f) in a pattern similar to that of the endogenous Mesp genes (Takahashi et al., 2000; Saga et al., 1999) . These data indicate that this BAC clone contains most of the elements required for the faithful expression of Mesp1 and Mesp2 during early embryogenesis, at least until E10.5.
2.2.
Analyses of the early mesoderm enhancers for Mesp1 and Mesp2
We previously identified the enhancers required for the early mesoderm expression of Mesp1 (previously referred to as P1-EME) and also for the PSM-specific expression of Mesp2 (P2-PSME) using a conventional transgenic strategy (Haraguchi et al., 2001) . To confirm these results and also to identify the enhancers required for the early mesoderm expression of Mesp2 and PSM expression of Mesp1, we utilized our BAC dual reporter, BAC-P1AP-P2Z. Using a third kanamycin vector containing FRT2 (Schlake and Bode, 1994) , we introduced deletions into this BAC vector. Initially we deleted P1-EME from the BAC construct to generate BAC-P1AP-P2Z (D1) ( Fig. 2A and B) . ALP expression was then analyzed using transient transgenic embryos recovered at E7.5. Unexpectedly, all of the transgenic embryos that we recovered (5/5) showed ALP expression in the early mesoderm ( Fig. 2C, a) , indicating that the enhancers driving Mesp1 in the early mesoderm are not only contained within P1-EME.
To explore other possible enhancers, we used Pipmaker software to analyze the human genome and found several conserved sequences between the Mesp1 and Mesp2 intergenic region ( Fig. 2A) . We then generated a corresponding deletion in the BAC reporter, to produce BAC-P1AP-P2Z (D2), and the resulting transient transgenic embryos (4/6) showed ALP activity in the early mesoderm (Fig. 2C, b) . However, using the BAC-P1AP-P2Z (D1D2) construct, which lacks both region-1 (containing P1-EME), and region-2, no ALP-positive embryo was recovered (Fig. 2C, c) . This indicates that enhancers exist in both region-1 (containing P1-EME) and region-2. Interestingly the expression of Mesp2 in the early mesoderm was still observed when using BAC-P2AP (D1D2D3) (Fig. 2C, d ), indicating that Mesp2 uses a different enhancer outside of regions-1 (containing P1-EME) to -3 for its expression there.
2.3.
Identification of a PSM-specific enhancer for Mesp1
Based upon our previous study, we had already noted that the Mesp1 PSM enhancer also resides in the P1-EME, in addition to the early mesoderm enhancer for this gene (Haraguchi et al., 2001) . To identify this Mesp1 PSM enhancer, we further focused on the region-1, which contains P1-EME, and generated PIS1 and P1S2 constructs using ALP as a reporter (Fig. 3A) . We then analyzed their expression in the PSM (ALP activity in the somitic region) using E10.5 embryos. The results clearly showed that the Mesp1 enhancer resides within the deleted 1300 bp region ( Fig. 3A and B, a and b). Using a Pipmaker search we further identified a highly conserved 200 bp and other genes and a schematic depiction of the strategy used to introduce two reporters, ALP and nlacZ, into the Mesp1 and Mesp2 loci in this construct. (B) Schematic representation of the BAC modification method used in this study which utilized a reporter gene cassette harboring a kanamycin resistance gene flanked by two FRT sequences. The DNA fragment required for homologous recombination was generated by PCR using Primer A and Primer B, which contain corresponding genomic sequences A and B, respectively. The reporter gene containing the kanamycin cassette was then introduced into a BAC clone using the k red recombination system (see Section 4). (C) Sequences of three different FRTs used for sequential recombination. These sequences differ in terms of their spacers (shown in red). After one recombination event, the kanamycin gene cassette can be deleted by Flp and an additional recombination reaction can be initiated using an additional vector with a different FRT, which never recombines with the others. (D) Results of the transient transgenic analyses using the BAC vector, BAC-P1AL-P2Z. Both reporter activities were observed in the somitic region at E10.5 (a-d) and in the early mesoderm at E7.5 (e and f). Positive ALP (red) and b-gal (blue) expression indicates an active Mesp1-and Mesp2-reporter, respectively. The numbers of stained embryos among the PCR-positive cohort are indicated in each panel. Sections were prepared after whole mount staining to reveal the expression pattern in detail (b and d).
subregion within the 1300 bp region, and this subregion showed enhancer activity when it was ligated to either the Mesp1 minimum promoter or a hsp-LacZ promoter cassette ( Fig. 3A and B, c-f) .
The 200-bp subregion contains several common sequences with P2-PSME, including a T-box binding site, which was shown to be pivotal in the activation of Mesp2 in the PSM , and an E-box (Fig. 4A) . To investigate whether these T-box binding site and E-box are functionally involved in the expression of Mesp1, we introduced mutations into these sequences separately (Fig. 4A) . As clearly shown in Fig. 4B and C, no PSM-specific expression could be observed using either transgene harboring such mutations, confirming that the both T-box binding sequence and E-box are indeed required for Mesp1 activation in the PSM. We thereafter designate this 200-bp subregion as P1-PSME (stands for Mesp1-PSM enhancer).
PSM enhancer specificity for Mesp1 and Mesp2
To investigate the specificity of the PSM enhancer, we established a stable transgenic line and examined the reporter activities of BAC-P1AP-P2Z (D1) from which the P1-PSME region was removed (Fig. 5A) . The resulting transgenic embryos that we recovered at E10.5 did not show ALP expression, but their b-gal expression was found to be intact (Fig. 5A, a and  b) . To explore whether these transgenic mice retained their early mesodermal enhancer activity, we examined Mesp1 and Mesp2 expression in the early mesoderm. The embryos harboring BAC-P1AP-P2Z (D1) retained ALP expression in the early mesoderm only (Fig. 5A , c-e), whereas embryos containing the original construct, BAC-P1AP-P2Z, retained this reporter expression in both the early mesoderm and the PSM (Fig. 5A, f-h) .
We also constructed BAC-P1AP-P2Z(D4) in which the P2-PSME region was removed from BAC-P1AP-P2Z (Fig. 5B) . The resulting transgenic embryos did not show b-gal expression but their ALP expression was intact (Fig. 5B, a and b) . These data indicate that Mesp1 and Mesp2 use different enhancers, P1-PSME and P2-PSME, respectively, for their expression in the PSM.
2.5.
Generation and analysis of PSM-specific Mesp1/ Mesp2 double null mice
Since we had successfully identified PSM-specific enhancers for both Mesp1 and Mesp2, we were then able to generate a PSM-specific dKO mouse by rescuing the early lethality of the dKO mouse. We attempted to establish a transgenic mouse line that expressed Mesp1 only in the early mesoderm. Accordingly, we generated a BAC-P2AP (stands for BACMesp2-ALP) (D1) line as this BAC clone lacks P1-PSME in addition to the Mesp2 gene (Fig. 6A) . The Mesp1/Mesp2 dKO À/À mouse displayed embryonic lethality during early development, as previously reported . However, by intercrossing this mouse with BAC-P2AP (D1), we predicted that there would be a rescue of these early mesodermal defects, and that a PSM-specific Mesp1/Mesp2-null mouse would be obtained. BAC-P2AP (D1) embryos, indicating the rescue of the early lethality phenotype in the dKO mouse.
The dKO À/À BAC-P2AP (D1) embryos had no segmented somites at E10.5, which was an expected defect resulting from the lack of Mesp proteins. We have previously generated several Mesp2-null mice including Mesp2-null with pgk-neo (Mesp2 Neo/Neo ), Mesp2-LacZ knockin with pgk-neo (Mesp2 lacZ/lacZ ) and Mesp2-MCM without pgk-neo (Mesp2 MCM/MCM ) (Saga et al., 1997; Takahashi et al., 2000 Takahashi et al., , 2007 . These knockout animals show differences in the severity of their segmentation defects due to the different levels of rescue by Mesp1, and also the effects of the pgk-neo cassette. The Mesp2-null mouse that displayed the mildest phenotype, Mesp2
MCM/MCM
, showed segmental border formation, but the rostro-caudal polarity of the somites was disrupted (Takahashi et al., 2007) . The dKO À/À BAC-P2AP (D1) embryos in our current study had no segmental border (Fig. 6B, a and b) , and also showed fused pedicles of the neural arches, similar to that of the Mesp2 lacZ/lacZ embryo (Fig. 6B, c and d ). Given that this transgenic embryo should lack Mesp1 expression in the PSM, based upon our current strategy, we tested whether this was indeed the case. Unexpectedly however, the transgenic lines still showed a slight expression of Mesp1 (Fig. 6C, a and b) although the levels were much lower than any of the other Mesp2-null embryos (Takahashi et al., 2007) . These results indicate that minor regulatory elements for Mesp1 expression other than P1-PSME do exist. We then examined other molecular markers to further characterize our rescued dKO embryos. EphA4 is a direct target of Mesp2 (Nakajima et al., 2006) and is implicated in segment boundary formation during zebrafish somitogenesis (Barrios et al., 2003) . In the dKO À/À BAC-P2AP (D1) embryos, the normal stripe-like expression pattern of EphA4 in the anterior PSM was not observed (Fig. 6C, c and d) . The expression of Uncx4.1 was found to be localized in the caudal half of the somites in the control embryo (Mansouri et al., 1997) but to be uniformly expanded in the dKO À/À BAC-P2AP (D1) mutant (Fig. 6C , e and f). These phenotypes were quite similar to that of Mesp2 lacZ/lacZ embryo, which had shown the most severe Mesp2-null phenotype. Taken together, we conclude from our present data that the dKO À/À BAC-P2AP (D1) is a PSM-specific Mesp1/Mesp2-null mouse.
Discussion
The BAC modification system and associated transgenic strategy is a powerful tool in the analysis of gene activities
The BAC modification system is regarded as a very powerful method for reproducing endogenous gene expression without the prior need to determine the enhancer region, as well as to investigate the enhancer activity itself of the gene under study. We have further developed the sequential modification system for a single BAC gene in our current study by establishing cassettes harboring a kanamycin-resistant selection gene flanked by different sets of FRT sequences (Schlake and Bode, 1994) . We used this system to first explore the enhancer regions of the mouse Mesp1 and Mesp2 genes and found it to be particularly useful in the analysis of paralogous genes which show similar expression patterns, as it is difficult to identify a gene-specific enhancer under these circumstances using a conventional transgenic strategy. By introducing different reporters into each gene locus, we could address the specificity of each enhancer.
In previous transgenic analyses, we identified a possible Mesp1 early mesoderm enhancer (P1-EME in Fig. 2 ) that can drive reporter expression in the early mesoderm. However, we were unsure whether this element was required for the expression of Mesp1, Mesp2, or both. By deleting the enhancer in the context of a dual reporter we could determine its gene specificity. However, deleting this region from our BAC construct did not eliminate reporter activity for Mesp1, indicating that other enhancer elements reside in this clone. We also identified an additional enhancer region by further deleting the flanking regions in the BAC construct. This enhancer was found to be required for Mesp1 but not Mesp2, indicating that Mesp2 uses another enhancer for its expression in the early mesoderm, although it was still possible that Mesp2 also uses the deleted enhancer. Hence, the BAC system is useful for performing enhancer analysis within an endogenous genomic context, although enhancer-specific gene knockout analysis would still be the most desirable approach to undertake, if it is possible to do.
A Tbx6-binding site is essential for the Mesp1 enhancer
We previously showed that Tbx6 directly binds to the PSMspecific enhancer of Mesp2 (P2-PSME) and is essential for the activation of its expression . In our present study, we show that the T-box binding sequence is also essential for the activation of Mesp1 in the PSM. In both zebrafish and medake, Tbx24, a distant homolog of mouse Tbx6, has been shown to bind to the mespb upstream region (Terasaki et al., 2006) . In the simple chordate Ciona intestinalis during heart development, Ci-Mesp, a homolog of the vertebrate Mesp family, is also expressed in a Tbx6-dependent manner, and Tbx6 also binds to Ci-Mesp upstream regions (Davidson et al., 2005) . Based upon these previous reports, we speculated that the Tbx6-dependent activation of the Mesp genes is an evolutionally conserved mechanism in Chordates. However, the complicated regulation of Mesp genes during somitogenesis cannot be explained only by Tbx6. In this regard, Mesp2 is known to be regulated by Notch signaling also and it was thus interesting to find that an E-box is required for Mesp1 expression in the PSM but not for Mesp2 (data not shown), indicating that a different mechanism is involved in the regulation of Mesp1 in addition to a Tbx6-dependent common mechanism. 
3.3.
The phenotype of the PSM-specific Mesp1/Mesp2-null mouse Mesp paralogs are thought to play crucial roles during somitogenesis in vertebrates and the two vertebrate Mesp genes are localized in close proximity on the same chromosome in mouse, chick, zebrafish and Xenopus (Buchberger et al., 1998; Sawada et al., 2000; Sparrow et al., 1998) . However, the precise function of paralogous Mesp genes in somitogenesis has remained elusive, although some redundancy of function has been shown from overexpression studies in zebrafish and Xenopus (Sawada et al., 2000; Sparrow et al., 1998) , in addition to mouse knockout and knockin studies from our laboratory Saga, 1998; Saga et al., 1997; Takahashi et al., 2000 Takahashi et al., , 2005 Takahashi et al., , 2007 . The phenotype of the PSM-specific Mesp1/Mesp2-null embryos generated in our current study resembled the Mesp2 lacZ/lacZ mouse we previously reported for a Mesp2-single knockout mouse (Takahashi et al., 2000) . In the Mesp2 lacZ/lacZ embryos, we found that no segmental border was generated and that the levels and pattern of Mesp1 expression were altered (Takahashi et al., 2007) . In contrast, the other Mesp2-single knockout mouse, Mesp2
MCM/MCM
, retained the ability to generate segmental borders. The major difference in this instance was the Mesp1 expression pattern, in which the level of this gene was up-regulated and their expression pattern showed a clear anterior border.
The PSM-specific Mesp1/Mesp2-null mouse we created in our present study still showed marginal Mesp1 expression. The reason for this is currently unknown but it is possible that minor regulatory elements other than P1-PSME could affect the expression of Mesp1. Alternatively, some cryptic enhancer might be activated in the absence of endogenous gene expression. Nevertheless, we confirmed our initial prediction that Mesp proteins have a redundancy of function in the anterior PSM, and that no segmental border is generated and the rostro-caudal polarity of the somites is not established in the absence of any Mesp protein function.
In conclusion, our current rescue protocol using BAC constructs is a useful tool for the further analysis of the properties of Mesp proteins in early mesodermal cells and in the anterior PSM. By modifying one gene in combination with a disruption of the other, and introducing the corresponding BAC construct into the dKO genetic background as shown herein, we could evaluate the functional significance of this modification without any concerns regarding the activity of the other gene. Fig. 5 -The enhancer specificity of P1-PSME and P2-PSME. (A) BAC-P1AP-P2Z (D1) was generated by deleting region-1, which contains the P1-PSME enhancer, from BAC-P1AP-P2Z via a third round of recombination using FRT2 (Fig. 2B) . The transient transgenic embryo harboring this construct showed no ALP activity that would indicate Mesp1 expression (a), but the LacZ mRNA expression for Mesp2 was found to be intact in the PSM (arrow in (b)). ALP activities were examined in embryos derived from stable transgenic lines harboring P1AP-P2Z (D1) (c-e) or P1AP-P2Z (f-h) at E7.5 (c and f) or at E8.5 (d and e, g and h). The former lacks ALP expression in the somitic region (compare (e) and (h)). (B) BAC-P1AP-P2Z (D1) was found not to express Mesp2, but its Mesp1 expression was intact (a and b).
4.
Experimental procedures 4.1.
BAC modification system BAC DNA modifications were conducted using the k red recombination method as described previously (Datsenko and Wanner, 2000) . Briefly, we utilized 70 nt primers with 50 nt of homology to the gene of interest at the 5 0 end and 20 nt of homology to the FRT-flanked kanamycin resistance cassettes at the 3 0 end (Fig. 1B, Supplementary Table S1 ). The resulting PCR products were concentrated using Qiagen PCR purification columns. We generated electroporation-competent DH10 BAC host cells and then transformed them with PKD46 which carries the k recombination genes gam, bet and exo under the control of the araBAD promoter (Datsenko and Wanner, 2000) . Colonies hosting both BAC and pKD46 were grown overnight at 30°C and diluted 1/100 in LB Amp/0.1 M L-arabinose and grown to an OD 600 of 0.6. Electrocompetent cells were prepared and transformed with approximately 500 ng of PCR product and recovered in 1 ml of SOC for 2 h and plated onto LB plates containing chloramphenicol and kanamycin at 37°C. The resulting colonies were then characterized using specific PCR. The kanamycin resistance cassette was then removed by introduction of a pCP20 plasmid (resistant to both chloramphenicol and ampicillin), which shows temperature-sensitive replication and thermal induction of FLP synthesis. To achieve this, Cm-R and Km-R clones were transformed with pCP20, and after once selected on plates with chloramphenicol and ampicillin at 30°C, a few clones were colony-purified at 42°C. We then used a duplicate plate strategy to screen for colonies that has lost kanamycin resistance, and confirmed this by PCR.
Generation of transgenic mice
All constructs were digested with restriction enzymes to remove vector sequences and then gel purified. Transgenic mice were generated by microinjection of fertilized eggs. Microinjected eggs were then transferred into the oviducts of pseudopregnant foster females. In most cases, we sacrificed the foster mouse to recover embryos at E7.5 or E10.5. The genotypes of the embryos were identified by PCR using yolk sac DNA. The primers used in this study are shown in Supplemental Table S1.
4.3.
Generation of the PSM-specific Mesp1/Mesp2 double-null mouse Permanent transgenic mouse lines were established by injection with the BAC-P2AP (D1) construct. The F0 mouse was then crossed with a heterozygous dKO mouse that has been previously established to yield double heterozygotes. These mice were intercrossed and embryos were recovered at E10.5. Genotyping was then conducted to analyze the dKO alleles and the ALP transgene. 
4.4.
Analyses of embryos by LacZ staining, in situ hybridization, histological methods and skeletal preparations Embryos were fixed and stained in X-gal solution for the detection of b-gal activity, as described previously (Saga et al., 1999) . For histological analyses, samples stained by X-gal were postfixed with 4% paraformaldehyde, dehydrated in an ethanol series, embedded in paraffin and sectioned at 6 lm. Whole mount in situ hybridizations were performed using InsituPro robot (Intavis). The transcripts were visualized using anti-digoxygenin (DIG) antibodies conjugated to alkaline phosphatase. Color reactions were performed using BM Purple (Roche). Probes used for the in situ hybridization detection of Uncx4.1 were kindly provided by Dr. Peter Gruss. The generation of skeletal preparations stained with Alcian blue/Alizarin red has been described previously (Saga et al., 1997) .
